openPR Logo
Press release

Physician Dispensed Cosmeceuticals Market Opportunity Will Rise to US$ 31,322.14 Mn by 2026

10-10-2019 03:42 PM CET | Health & Medicine

Press release from: Transparency Market Research

Physician Dispensed Cosmeceuticals Market Opportunity Will

Global Physician Dispensed Cosmeceuticals Market – Snapshot

Physician dispensed cosmeceuticals are cosmetic products that contain active ingredients to target the clinically visible signs of aging, infection, or other imperfections in one’s personal appearance.

The market is expected to expand at a rapid pace, marked by a sea change in market dynamics, with dermatologists, trichologists, and skin care specialists turning into entrepreneurs. Consequently, the market is gradually becoming fragmented due to mushrooming skin and hair clinics and treatment centers, which are startups by physicians who prescribe branded cosmeceuticals products. Some of these physician-turned entrepreneurs also recommend locally manufactured low-cost products developed by their own clinics.

Obtain Report Details @ https://www.transparencymarketresearch.com/physician-dispensed-cosmeceuticals-market.html

Dermatologists claim that there is an increasing tendency of pharmacy benefit managers as well as consumers to reject cosmeceuticals that are not able to produce visible results and are expensive. Therefore, the product should prove its claims to remain competitive in this market. The global physician dispensed cosmeceuticals market was valued at US$ 13,146.80 Mn in 2017. It is expected to expand at a CAGR of 10.3% from 2018 to 2026.

1global physician dispensed cosmeceuticals market
The global physician dispensed cosmeceuticals market has been segmented based on product type and region. Furthermore, in terms of product type, the market has been divided into skin care products, hair care products, eye care products, injectable Botox, and others. The skin care products segment accounted for a prominent share of the global physician dispensed cosmeceuticals market in 2017, as the nature of cosmeceuticals demanded by consumers is largely to treat dermatological conditions.

Increasing awareness about personal maintenance among the geriatric population and changing attitudes of middle-aged and geriatric population in developing countries have fuelled the demand for cosmeceuticals in order to eliminate the outwardly signs of aging. The anti-aging segment is expected to maintain its dominance in the market during the forecast period. Similarly, dermal fillers and injectable Botox segments are expected to expand considerably from 2018 to 2026.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=565

In terms of region, the global physician dispensed cosmeceuticals market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is mature and technically developed, as compared to the other regions. Hence, the region accounted for a notable share of the global market, in terms of revenue, in 2017. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. Increasing preference to retain beauty and youthful appearance propels the demand for effective cosmeceuticals. These factors are expected to drive the market in this region.

Similarly, other emerging markets such as Brazil, South Africa, the UAE, and Saudi Arabia are expected to expand at a steady pace during the forecast period. High revenue generating cosmeceutical products such as injectable Botox and dermal fillers have a minuscule consumer base in underdeveloped and developing regions due to high cost, lack of sufficient knowledge, apprehensions, and lower popularity among end-users.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=565

Key players operating in the global physician dispensed cosmeceuticals market include Allergan plc, Jan Marini Skin Research, Inc., Johnson & Johnson, L’Oreal S.A., Procter & Gamble Co., Bausch Health Companies Inc., Unilever plc, and ZO Skin Health Inc., and L’Oreal S.A. These companies have diverse product offerings and extensive distribution systems across the world. Moreover, entry of small players, especially in the emerging markets of Asia, is being witnessed. However, stringent regulatory framework and high-quality standards set by market leaders are anticipated to restrain the penetration of new entrants in the market.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Physician Dispensed Cosmeceuticals Market Opportunity Will Rise to US$ 31,322.14 Mn by 2026 here

News-ID: 1846359 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for Physician

Physician Scheduling Systems Market 2026
This report focuses on the global Physician Scheduling Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Physician Scheduling Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Spok ABILITY Network Qgenda Intrigma OpenTempo Medevision Mediware Information Systems MDSYNCNET Jituzu Lightning Bolt Solutions McKesson Business Management Systems Market segment by Type, the product can be split into Software Services Market segment by Application, split
The Physician-Patient Relationship in Telemedicine
Telemedicine should be the modality used when considered to be in the best interest of the patient, for example when it can advance the possibility of treatment otherwise inaccessible, or where contact or physical presence in a clinical setting is not possible due to various constraints brought on by, geography or accessibility, illness or incapacitation, or being part of the medically underserved urban and rural populations. Is
Third Physician Group and First Orthopedic Practice Joins White Plains Hospital …
White Plains Hospital recently welcomed Westchester Orthopaedic Associates to its larger family. The practice of Louis McIntyre, M.D.; Michael Panio, M.D.; and Eric Zitzmann, M.D. is the third physician group to join the White Plains Hospital Physician Associates, a recently formed division of the hospital aligning local doctors with Hospital services. This new venture enables physicians and White Plains Hospital to share information, promote growth, better utilize resources
First Physician Group Joins White Plains Hospital Physician Associates
White Plains, NY – White Plains Hospital recently welcomed White Plains Surgical Specialists, formerly known as Weber, Weber and Yee, to the White Plains Hospital family. Additionally, as of August 1st, surgeon Kaare Weber joined the group. The practice becomes the first member of White Plains Hospital Physician Associates, a newly formed division of the Hospital, developed with the intent of aligning local practicing physicians with the Hospital. This new
Physician Assistant Programs 101 Guides Career Hopefuls On The Path To Becoming …
The health care industry is a growth sector of the American economy with thousands of jobs expected to be open in the coming years. It was once thought that health care was little more than doctors and nurses, but that has changed dramatically. New professions have grown up within the industry and physician assistant is one of them. It is anticipated that this one job category alone will experience growth
UCLA Physician Named Care Champion
The National Association For Continence (NAFC) awarded Shlomo Raz, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics & Female Urology (SUFU) annual meeting in St. Petersburg, FL on February 26, 2010. The honor, presented by Eric Rovner, MD, professor of Urology at the Medical University of South Carolina and a member of NAFC’s Board of Directors, is sponsored by Pfizer Global Pharmaceuticals. Originally